XML 88 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 27, 2015
Sep. 28, 2014
Net cash provided by operating activities $ 1,020,957 $ 966,868
Cash flows from investing activities:    
Capital expenditures (139,054) (120,316)
Origination of finance receivables (3,112,827) (2,918,881)
Collections on finance receivables 2,393,355 2,308,237
Sales and redemptions of marketable securities 9,500 41,010
Business Combination, Consideration Transferred (59,910) 0
Other 5,172 275
Net cash used by investing activities (903,764) (689,675)
Cash flows from financing activities:    
Proceeds from Issuance of Unsecured Debt 740,949 0
Repayments of Unsecured Debt 0 (303,000)
Proceeds from Issuance of Medium-term Notes 595,386 594,431
Repayments of Medium-term Notes 600,000 7,220
Proceeds from Securitization Debt 1,195,668 847,126
Repayments of Securitization Debt 764,909 631,302
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt 258,734 (315,278)
Borrowings of asset-backed commercial paper 69,191 57,669
Repayments of asset-backed commercial paper (55,124) (58,717)
Net change in restricted cash (15,165) 2,521
Dividends paid (191,451) (179,860)
Purchase of common stock for treasury (894,565) (393,459)
Excess tax benefits from share-based payments 2,878 8,873
Issuance of common stock under employee stock option plans 16,755 28,850
Net cash provided by (used by) financing activities 358,347 (349,366)
Effect of exchange rate changes on cash and cash equivalents (13,666) (14,573)
Net increase (decrease) in cash and cash equivalents 461,874 (86,746)
Cash and cash equivalents:    
Cash and cash equivalents—beginning of period 906,680 1,066,612
Net increase (decrease) in cash and cash equivalents 461,874 (86,746)
Cash and cash equivalents—end of period 1,368,554 979,866
Financial Services Operations [Member]    
Net cash provided by operating activities 602,978 542,120
Cash flows from investing activities:    
Capital expenditures (4,890) (4,720)
Origination of finance receivables (6,512,799) (6,417,038)
Collections on finance receivables 5,656,189 5,613,949
Sales and redemptions of marketable securities 0 0
Other 0 0
Net cash used by investing activities (861,500) (807,809)
Cash flows from financing activities:    
Proceeds from Issuance of Unsecured Debt 0  
Repayments of Unsecured Debt   0
Proceeds from Issuance of Medium-term Notes 595,386 594,431
Repayments of Medium-term Notes 600,000 7,220
Proceeds from Securitization Debt 1,195,668  
Repayments of Securitization Debt 764,909 631,302
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt 258,734 (315,278)
Repayments of asset-backed commercial paper   (58,717)
Net change in restricted cash (15,165) 2,521
Dividends paid (100,000) (120,000)
Purchase of common stock for treasury 0 0
Excess tax benefits from share-based payments 0 0
Issuance of common stock under employee stock option plans 0 0
Net cash provided by (used by) financing activities 333,781 269,230
Effect of exchange rate changes on cash and cash equivalents (2,850) (1,509)
Net increase (decrease) in cash and cash equivalents 72,409 2,032
Cash and cash equivalents:    
Cash and cash equivalents—beginning of period 332,785 347,700
Net increase (decrease) in cash and cash equivalents 72,409 2,032
Cash and cash equivalents—end of period 405,194 349,732
Motorcycles And Related Products Operations [Member]    
Net cash provided by operating activities 655,117 737,193
Cash flows from investing activities:    
Capital expenditures (134,164) (115,596)
Origination of finance receivables 0 0
Collections on finance receivables 0 0
Sales and redemptions of marketable securities 9,500 41,010
Other 5,172 275
Net cash used by investing activities (179,402) (74,311)
Cash flows from financing activities:    
Proceeds from Issuance of Unsecured Debt 740,949  
Repayments of Unsecured Debt   (303,000)
Proceeds from Issuance of Medium-term Notes 0 0
Repayments of Medium-term Notes 0 0
Proceeds from Securitization Debt 0  
Repayments of Securitization Debt 0 0
Proceeds from (Repayments of) Credit Facility and Other Unsecured Debt 0 0
Repayments of asset-backed commercial paper   0
Net change in restricted cash 0 0
Dividends paid (191,451) (179,860)
Purchase of common stock for treasury (894,565) (393,459)
Excess tax benefits from share-based payments 2,878 8,873
Issuance of common stock under employee stock option plans 16,755 28,850
Net cash provided by (used by) financing activities (75,434) (738,596)
Effect of exchange rate changes on cash and cash equivalents (10,816) (13,064)
Net increase (decrease) in cash and cash equivalents 389,465 (88,778)
Cash and cash equivalents:    
Cash and cash equivalents—beginning of period 573,895 718,912
Net increase (decrease) in cash and cash equivalents 389,465 (88,778)
Cash and cash equivalents—end of period $ 963,360 $ 630,134